Ascentage Pharma Group International (HKG:6855)
Hong Kong · Delayed Price · Currency is HKD 63.30
+0.10 (0.16%)
Nov 19, 2025, 4:08 PM HKT
HKG:6855 Market Cap
HKG:6855 has a market cap or net worth of 23.3 billion as of November 19, 2025. Its market cap has increased by 65.41% in one year.
Market Cap
23.30B
Enterprise Value
23.37B
Revenue
428.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
63.30
Market Cap Chart
Since October 28, 2019, HKG:6855's market cap has increased from 7.59B to 23.30B, an increase of 207.04%. That is a compound annual growth rate of 20.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2025 | 23.26B | 65.30% |
| Dec 31, 2024 | 14.07B | 81.16% |
| Dec 29, 2023 | 7.77B | 17.12% |
| Dec 30, 2022 | 6.63B | -8.70% |
| Dec 31, 2021 | 7.26B | -14.53% |
| Dec 31, 2020 | 8.50B | 39.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 313.45B |
| Hansoh Pharmaceutical Group Company | 236.23B |
| JD Health International | 214.50B |
| Innovent Biologics | 154.92B |
| WuXi Biologics | 130.87B |
| Sino Biopharmaceutical | 124.78B |
| Akeso | 103.08B |
| Sichuan Kelun-Biotech Biopharmaceutical | 101.34B |